Samuel Redondo is the director and head of life sciences and in charge of evaluating new investment opportunities in the life sciences sector, to keep emerging business development insights at the forefront of Quantum EQT.

Prior to joining Quantum EQT, Samuel worked for a Hedge fund in London and at the International Trade Centre in Switzerland. Furthermore, Samuel was part of the trade policy review team in the WTO who reviewed Pharma agreements

Samuel graduated his BSc. In Business Management and Economics, and holds a MSc. In Economics and International Development from Kings College in London and was a Chatham House Fellow for the 2018 London conference.

Samuel is part of the five-person executive committee who is in charge of making final decisions on investments.

Languages
English
Spanish